Artica Therapeutics
Latest round
- Seed
Last raised
- Nov 2023
Total raised
- $12M
Investors
- 4
About Artica Therapeutics
Based in Leiden, Netherlands, and founded in 2020 by CEO Tjeerd Barf, COO Arwin Ridder, and Prof. Ad IJzerman, Artica Therapeutics BV operates as a biotechnology company that researches and develops medications with small molecules for autoimmune and inflammatory symptoms. The company is developing novel therapies by leveraging covalent chemistry and label-free cellular-based screening approaches for patients suffering from severe autoimmune and inflammatory disorders.
Who invested in Artica Therapeutics
4 investors across 1 round
See all investors in Artica Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 2, 2023
Amount
$12M
Investors
Questions about Artica Therapeutics
Who invested in Artica Therapeutics?
Artica Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Artica Therapeutics raised?
Artica Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Artica Therapeutics last raise money?
Artica Therapeutics's most recent round on record is a Seed, in Nov 2023.
What does Artica Therapeutics do?
Based in Leiden, Netherlands, and founded in 2020 by CEO Tjeerd Barf, COO Arwin Ridder, and Prof.
Where is Artica Therapeutics headquartered?
Artica Therapeutics is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Artica Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Artica Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Artica Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.